Americans are still debating whether to roll up their sleeves for a swine flu shot, but companies have already figured it out: vaccines are good for business.
Drug companies have sold $1.5 billion worth of swine flu shots, in addition to the $1 billion for seasonal flu they booked earlier this year. These inoculations are part of a much wider and rapidly growing $20 billion global vaccine market.
Full Story »
To:
Separate email addresses with commas.
25 recipients max.
Note:
The article include very questionable experts, a comedian and a quack at least. A few other are more qualified. No mention is made of the huge government purchases of Tamiflu from Gilead (benefiting Rumsfelt). No quantification of the risks compared to other prominent causes of death, which would put better perspective on the hysteria.
A recent article suggests that the 1918 epidemic (which severely affected one of my uncles) was severely aggravated by huge doses of aspirin, which ... More »
Good report on money involved in vaccinations. An important space the piece doesn't explore is whether the CDC, who is promoting the swine flu vaccine, has anything to gain in seeing big pharma profit.
Finally a reporter is covering the profit angle of vaccine production. Vaccine manufacturing is not profitable unless there is a pandemic--or a scare of one--as we are seeing with H1N1. (Reports routinely are omitting how many people have died from regular flu so coverage has seemed sensational, feeding the profit chain.)
The Obama administration and his health secretary Kathleen Sebelius have been engaged in an advocacy campaign, stating the H1N1 shot has been ... More »
As always with pandemic flus, taxpayers are footing the $1.5 billion check for the 250 million swine flu vaccines that the government has ordered so far and will be ... More »
Thorough report about swine flu vaccines and who benefits from them: big pharma companies like Sanofi-Pasteur, Glaxo Smith Kline and Novartis. This article provides detailed factual evidence from many credible sources, citing physicians, researchers and industry representatives to give a contextual overview of this newsworthy topic.
This is quality journalism because it gives certain outlooks on swine flu that are set up as three different chapters or articles themselves. It goes on to site numerous sources in an array of fields that gives the reader a glance from a number of different views.
This article has a lot of information I have read everywhere else about the swine flu and vaccinations. It brings up really how much these vaccinations, which aren't even proven to be a good or healthy thing are being used for millions of dollars in profit. I feel like this is a hard thing to report on: the shots haven't been proven either way to be effective or safe, therefore we can't be sure what is helping or hurting.
Retrieving Comments
